J. Moreno

zidovudine factor and erythropoietin decreases hematologic toxicity from Combined therapy with recombinant granulocyte colony-stimulating

G. Baldwin, J. Glaspy, S. Miles, 2011 .

Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine.

G. Baldwin, J. Glaspy, S. Miles, 1991, Blood.

Recombinant human granulocyte colony-stimulating factor increases circulating burst forming unit-erythron and red blood cell production in patients with severe human immunodeficiency virus infection.

J. Egrie, J. Glaspy, K. Alton, 1990, Blood.